Neuropeptide Y (NPY).

[1]  L. Villani,et al.  Endorcine cells producing regulatory peptides , 1987, Experientia.

[2]  D. Groneberg,et al.  Expression of Immediate Early Genes in Sensory Ganglia , 2001, Neurochemical Research.

[3]  T. Hökfelt,et al.  Neuropeptide Y: presence in sympathetic and parasympathetic innervation of the nasal mucosa , 2004, Cell and Tissue Research.

[4]  D. Groneberg,et al.  Aspirin-sensitive rhinitis-associated changes in upper airway innervation , 2003, European Respiratory Journal.

[5]  S. Bonini,et al.  Animal models of allergic and inflammatory conjunctivitis , 2003, Allergy.

[6]  D. Groneberg,et al.  Calcitonin gene-related peptide as inflammatory mediator. , 2003, Pulmonary pharmacology & therapeutics.

[7]  U. Wahn,et al.  Down-regulation of vasoactive intestinal polypeptide receptor expression in atopic dermatitis. , 2003, The Journal of allergy and clinical immunology.

[8]  D. Groneberg,et al.  Toxic Rhinitis-Induced Changes of Human Nasal Mucosa Innervation , 2003, Toxicologic pathology.

[9]  Axel Fischer,et al.  Distribution of Respiratory Mucin Proteins in Human Nasal Mucosa , 2003, The Laryngoscope.

[10]  P. Hipskind,et al.  Recent Developments in Our Understanding of the Physiological Role of PP-Fold Peptide Receptor Subtypes 1 , 2003, Experimental biology and medicine.

[11]  P. Bradding.  The role of the mast cell in asthma: a reassessment , 2003, Current opinion in allergy and clinical immunology.

[12]  T. Yamamura,et al.  Relevance of Neuropeptide Y for the neuroimmune crosstalk , 2003, Journal of Neuroimmunology.

[13]  R. Bowler,et al.  Oxidative stress in airways: is there a role for extracellular superoxide dismutase? , 2002, American journal of respiratory and critical care medicine.

[14]  R. Quirion,et al.  Neuropeptide Y (NPY) and depression: from animal studies to the human condition. , 2002, Life sciences.

[15]  D. Groneberg,et al.  Innervation of Human Nasal Mucosa in Environmentally Triggered Hyperreflectoric Rhinitis , 2002, Journal of occupational and environmental medicine.

[16]  R. Bowler,et al.  Oxidative stress in allergic respiratory diseases. , 2002, The Journal of allergy and clinical immunology.

[17]  A. Beck‐Sickinger,et al.  Effect of neuropeptide Y on inflammatory paw edema in the rat: involvement of peripheral NPY Y1 and Y5 receptors and interaction with dipeptidyl-peptidase IV (CD26) , 2002, Journal of Neuroimmunology.

[18]  R. Malmström.  Pharmacology of neuropeptide Y receptor antagonists. Focus on cardiovascular functions. , 2002, European journal of pharmacology.

[19]  D. Groneberg,et al.  Mediators of asthma: nitric oxide. , 2002, Pulmonary pharmacology & therapeutics.

[20]  J. Harro,et al.  The neurocircuitry and receptor subtypes mediating anxiolytic-like effects of neuropeptide Y , 2002, Neuroscience & Biobehavioral Reviews.

[21]  A. Balasubramaniam.  Clinical potentials of neuropeptide Y family of hormones. , 2002, American journal of surgery.

[22]  A. Nicholson,et al.  Expression of respiratory mucins in fatal status asthmaticus and mild asthma , 2002, Histopathology.

[23]  D. Groneberg,et al.  Simultaneous detection of receptor mRNA and ligand protein in human skin tissues , 2002, Journal of cutaneous pathology.

[24]  A. Nicholson,et al.  Expression of MUC5AC and MUC5B mucins in normal and cystic fibrosis lung. , 2002, Respiratory medicine.

[25]  N. Frossard,et al.  Nerve growth factor and asthma. , 2002, Pulmonary pharmacology & therapeutics.

[26]  D. Groneberg,et al.  Abundant Expression of c-Jun in Guinea Pig Sympathetic Ganglia Under Basal Conditions and Allergen Challenge , 2002, Lung.

[27]  P. Henricks,et al.  Reactive oxygen species as mediators in asthma. , 2001, Pulmonary pharmacology & therapeutics.

[28]  P. Barnes,et al.  Cytokine modulators for allergic diseases , 2001, Current opinion in allergy and clinical immunology.

[29]  G. Folkerts,et al.  Reactive nitrogen and oxygen species in airway inflammation. , 2001, European journal of pharmacology.

[30]  D. Groneberg,et al.  Vasoactive intestinal polypeptide as mediator of asthma. , 2001, Pulmonary pharmacology & therapeutics.

[31]  P. Barnes,et al.  Histamine and serotonin. , 2001, Pulmonary pharmacology & therapeutics.

[32]  D. Groneberg,et al.  Endogenous opioids as mediators of asthma. , 2001, Pulmonary pharmacology & therapeutics.

[33]  D. Groneberg,et al.  Abundant expression of vasoactive intestinal polypeptide receptor VPAC2 mRNA in human skin. , 2001, The Journal of investigative dermatology.

[34]  M. Kavuru,et al.  Human alveolar macrophages and monocytes as a source and target for nitric oxide. , 2001, International immunopharmacology.

[35]  J. Renauld.  New insights into the role of cytokines in asthma , 2001, Journal of clinical pathology.

[36]  P. Barnes.  Cytokine modulators as novel therapies for airway disease , 2001, European Respiratory Journal.

[37]  J. Wilson,et al.  Assessing the evidence for remodelling of the airway in asthma. , 2001, Pulmonary pharmacology & therapeutics.

[38]  J. Moffatt,et al.  Protease-activated receptor-2 (PAR2) in the airways. , 2001, Pulmonary pharmacology & therapeutics.

[39]  M. Fuente,et al.  Changes with aging in the modulation by neuropeptide Y of murine peritoneal macrophage functions , 2001, Journal of Neuroimmunology.

[40]  D. Groneberg,et al.  Expression and Distribution of Vasoactive Intestinal Polypeptide Receptor VPAC2 mRNA in Human Airways , 2001, Laboratory Investigation.

[41]  F. Chung,et al.  Anti-inflammatory cytokines in asthma and allergy: interleukin-10, interleukin-12, interferon-gamma. , 2001, Mediators of inflammation.

[42]  P. Barnes,et al.  Th2 cytokines and asthma: an introduction , 2001, Respiratory research.

[43]  A. Loewy,et al.  Immunohistochemical localization of the neuropeptide Y Y1 receptor in rat central nervous system , 2001, Brain Research.

[44]  G. Rovati,et al.  Leukotrienes as mediators of asthma. , 2001, Pulmonary pharmacology & therapeutics.

[45]  M. Delgado,et al.  Neuropeptides as modulators of macrophage functions. Regulation of cytokine production and antigen presentation by VIP and PACAP. , 2001, Archivum immunologiae et therapiae experimentalis.

[46]  J. Schölmerich,et al.  Neuropeptide Y Cotransmission with Norepinephrine in the Sympathetic Nerve—Macrophage Interplay , 2000, Journal of neurochemistry.

[47]  R. Palmiter,et al.  Neuropeptide Y (NPY) potentiates phenylephrine-induced mitogen-activated protein kinase activation in primary cardiomyocytes via NPY Y5 receptors. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[48]  M. Levite.  Nerve‐Driven Immunity: The Direct Effects of Neurotransmitters on T‐Cell Function , 2000, Annals of the New York Academy of Sciences.

[49]  T. Hökfelt,et al.  Neuropeptide Y Innervation and Neuropeptide-Y-Y1-Receptor-Expressing Neurons in the Paraventricular Hypothalamic Nucleus of the Mouse , 1999, Neuroendocrinology.

[50]  A. Beck‐Sickinger,et al.  Molecular characterization of the ligand-receptor interaction of neuropeptide Y. , 1999, Current medicinal chemistry.

[51]  M. Mutter,et al.  Influence of TASP‐V, a novel neuropeptide Y (NPY) Y2 agonist, on nasal and bronchial responses evoked by histamine in anaesthetized pigs and in humans , 1999, British journal of pharmacology.

[52]  P S Kalra,et al.  Interacting appetite-regulating pathways in the hypothalamic regulation of body weight. , 1999, Endocrine reviews.

[53]  G. Sperk,et al.  Neuropeptide Y: emerging evidence for a functional role in seizure modulation , 1999, Trends in Neurosciences.

[54]  L. Tecott,et al.  Y Do We Drink? , 1998, Cell.

[55]  R. Straub,et al.  Centrally applied NPY mimics immunoactivation induced by non‐analgesic doses of met‐enkephalin , 1998, Neuroreport.

[56]  V. Fadok,et al.  Regulation of macrophage cytokine production by phagocytosis of apoptotic and post-apoptotic cells. , 1998, Biochemical Society transactions.

[57]  M. Levite.  Neuropeptides, by direct interaction with T cells, induce cytokine secretion and break the commitment to a distinct T helper phenotype. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[58]  M. Morris,et al.  Stimulation of Neuropeptide Y Overflow in the Rat Paraventricular Nucleus by Corticotropin‐Releasing Factor , 1998, Journal of neurochemistry.

[59]  V. Lagente,et al.  Tachykinins and airway function. , 1998, Pulmonary pharmacology & therapeutics.

[60]  M. Stalp,et al.  Brain NPY Y1 receptors rapidly mediate the behavioral response to novelty and a compartment-specific modulation of granulocyte function in blood and spleen , 1998, Brain Research.

[61]  J. Bousquet,et al.  Bronchial mucosal immunoreactivity of sensory neuropeptides in severe airway diseases. , 1998, American journal of respiratory and critical care medicine.

[62]  R. Schmidt,et al.  Modulation of innate immune functions by intracerebroventricularly applied neuropeptide Y: dose and time dependent effects. , 1998, Life sciences.

[63]  K. Fuxe,et al.  On the relationship of neuropeptide Y Y1 receptor-immunoreactive neuronal structures to the neuropeptide Y-immunoreactive nerve terminal networks. A double immunolabelling analysis in the rat brain , 1998, Neuroscience.

[64]  Satoshi Obana,et al.  Differential Effects of Neuropeptides on Cytokine Production by Mouse Helper T Cell Subsets , 1998, Neuroimmunomodulation.

[65]  B. Leonard,et al.  Comparison between the effects of sigma receptor ligand JO 1784 and neuropeptide Y on immune functions. , 1998, European journal of pharmacology.

[66]  M. Jackerott,et al.  Immunocytochemical Localization of the NPY/PYY Y1 Receptor in Enteric Neurons, Endothelial Cells, and Endocrine-like Cells of the Rat Intestinal Tract , 1997, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[67]  T. Hökfelt,et al.  Neuropeptide Y1 receptors in the rat genital tract , 1997, Regulatory Peptides.

[68]  Lacroix Js,et al.  Attenuation of allergen-evoked nasal responses by local pretreatment with exogenous neuropeptide Y in atopic patients , 1996 .

[69]  B. Waeber,et al.  Intranasal administration of neuropeptide Y in man: systemic absorption and functional effects , 1996, British journal of pharmacology.

[70]  E. Krause,et al.  Structure activity studies of mast cell activation and hypotension induced by neuropeptide Y (NPY), centrally truncated and C‐terminal NPY analogues , 1996, British journal of pharmacology.

[71]  A. Franco‐Cereceda,et al.  Sympathetic vascular control of the laryngeo-tracheal, bronchial and pulmonary circulation in the pig: evidence for non-adrenergic mechanisms involving neuropeptide Y. , 1995, Acta physiologica Scandinavica.

[72]  P. Howarth,et al.  Neuropeptide-containing nerves in endobronchial biopsies from asthmatic and nonasthmatic subjects. , 1995, American journal of respiratory cell and molecular biology.

[73]  J. Gies,et al.  Structural requirements for neuropeptide Y in mast cell and G protein activation. , 1995, European journal of pharmacology.

[74]  C. Bronner,et al.  Human and rat cutaneous mast cells: involvement of a G protein in the response to peptidergic stimuli. , 1995, European journal of pharmacology.

[75]  R. Håkanson,et al.  Neuropeptide Y and truncated neuropeptide Y analogs evoke histamine release from rat peritoneal mast cells. A direct effect on G proteins? , 1994, European journal of pharmacology.

[76]  K. Hirata,et al.  Effect of neuropeptide Y on human bronchus and its modulation of neutral endopeptidase. , 1993, The Journal of allergy and clinical immunology.

[77]  T. Takishima,et al.  Neuropeptide Y inhibits neurogenic inflammation in guinea pig airways. , 1993, Journal of applied physiology.

[78]  D. Reis,et al.  Neuropeptide Y-related peptides and their receptors--are the receptors potential therapeutic drug targets? , 1993, Annual review of pharmacology and toxicology.

[79]  M. Kaliner,et al.  Neuropeptide Y is a vasoconstrictor in human nasal mucosa. , 1992, Journal of applied physiology.

[80]  A. Cadieux,et al.  Inhibitory action of neuropeptide Y on agonist-induced responses in isolated guinea pig trachea. , 1992, European journal of pharmacology.

[81]  J. Shelhamer,et al.  The effects of neuropeptides on mucous glycoprotein secretion from human nasal mucosa in vitro , 1992, Neuropeptides.

[82]  C. Wahlestedt,et al.  C-terminal neuropeptide Y fragments are mast cell-dependent vasodepressor agents. , 1991, European journal of pharmacology.

[83]  J. Widdicombe.  Neural control of airway vasculature and edema. , 1991, The American review of respiratory disease.

[84]  M. Burnier,et al.  The role of neuropeptide Y in cardiovascular regulation. , 1991, Trends in pharmacological sciences.

[85]  R. Matran.  Neural control of lower airway vasculature. Involvement of classical transmitters and neuropeptides. , 1991, Acta physiologica Scandinavica. Supplementum.

[86]  P. Barnes,et al.  Neuropeptide Y modulates non-adrenergic, non-cholinergic neural bronchoconstriction in vivo and in vitro , 1989, Neuropeptides.

[87]  B. Wallin,et al.  Influence of sympathetic discharge pattern on norepinephrine and neuropeptide Y release. , 1989, The American journal of physiology.

[88]  J. Widdicombe,et al.  Effects of neuropeptides and capsaicin on the canine tracheal vasculature in vivo , 1988, British journal of pharmacology.

[89]  P. Barnes,et al.  Modulation of cholinergic neurotransmission in guinea‐pig trachea by neuropeptide Y , 1988, British journal of pharmacology.

[90]  U. Strömbom,et al.  Elevated plasma concentration of neuropeptide Y and low level of circulating adrenaline in elderly asthmatics during rest and acute severe asthma. , 1988, Pulmonary pharmacology.

[91]  R. Salonen,et al.  Vascular actions of airway neuropeptides. , 1987, The American review of respiratory disease.

[92]  C. Wahlestedt,et al.  Neuropeptide Y potentiates noradrenaline-evoked vasoconstriction: mode of action. , 1985, The Journal of pharmacology and experimental therapeutics.

[93]  L. Terenius,et al.  Evidence for differential localization of noradrenaline and neuropeptide Y in neuronal storage vesicles isolated from rat vas deferens , 1985, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[94]  J. Polak,et al.  Neuropeptide tyrosine (NPY): a newly discovered peptide is present in the mammalian respiratory tract. , 1984, Thorax.

[95]  C. Wahlestedt,et al.  Neuropeptide Y co-exists and co-operates with noradrenaline in perivascular nerve fibers , 1984, Regulatory Peptides.

[96]  V. Mutt,et al.  Neuropeptide Y—a novel brain peptide with structural similarities to peptide YY and pancreatic polypeptide , 1982, Nature.